MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common vitamin boost immunotherapy for melanoma?
Disease control OngoingThis early-phase trial is testing whether taking high-dose vitamin B5 (pantothenic acid) can help standard immunotherapy work better for people with advanced melanoma that cannot be surgically removed. The study includes 12 participants who have not had prior treatment for their …
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a 4-Week drug course keep melanoma from coming back?
Disease control OngoingThis study looked at whether giving high-dose interferon alfa-2b for four weeks after melanoma surgery helps keep the cancer from returning. About 1,150 people with stage II or III melanoma that was completely removed took part. Half got the drug and half were simply watched. The…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Smart drug schedule may improve melanoma treatment
Disease control OngoingThis early-phase study tested a new way of giving three drugs (encorafenib, binimetinib, and nivolumab) to people with advanced BRAF-mutant melanoma. Instead of taking the drugs every day, participants followed an on/off schedule to see if it could control the cancer while reduci…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
DNA vaccines aim to supercharge immune therapy against skin cancer
Disease control OngoingThis phase 2 trial is testing two experimental DNA vaccines, SCIB1 and iSCIB1+, in combination with standard immunotherapy drugs for people with advanced melanoma that cannot be removed by surgery. The study involves 173 participants and aims to see if adding these vaccines is sa…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Astrophysics meets dermatology: AI that maps moles like stars to catch melanoma early
Diagnosis OngoingThis study tests an AI tool called MoleGazer that uses total body photography to track moles over time, similar to how astrophysicists map the night sky. The goal is to automatically spot new or changing moles that could be early signs of melanoma. Researchers are recruiting peop…
Matched conditions: MELANOMA (SKIN)
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New PET scan tracks immune response in melanoma patients
Knowledge-focused OngoingThis early-phase trial tested a special PET/CT imaging agent, Zirconium Zr 89 Crefmirlimab Berdoxam, to see if it can measure immune activity in tumors of patients with advanced melanoma. Six adults on immunotherapy plus hydroxychloroquine received scans before and after starting…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC